These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14966104)

  • 1. Improved outcome with dose-dense chemotherapy.
    Keith B; Hall R; Scholnik A
    J Clin Oncol; 2004 Feb; 22(4):749; author rpely 751-3. PubMed ID: 14966104
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
    Hortobagyi GN
    J Clin Oncol; 1999 Nov; 17(11 Suppl):25-9. PubMed ID: 10630258
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.
    Antman KH
    J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?].
    Lopez M
    Clin Ter; 1999; 150(4):259-62. PubMed ID: 10605161
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dense chemotherapy for breast cancer: the story so far.
    Hudis C
    Br J Cancer; 2000 Jun; 82(12):1897-9. PubMed ID: 10864194
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose density by any other name.
    Hryniuk W; Ragaz J; Peters W
    J Clin Oncol; 2004 Feb; 22(4):750-1; author reply 751-3. PubMed ID: 14966105
    [No Abstract]   [Full Text] [Related]  

  • 10. [In search of Eldorado. Breast cancer and intensification therapy].
    Murillo Capitán E
    Med Clin (Barc); 1996 Jun; 107(3):95-8. PubMed ID: 8754496
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dose density and dose intensity in the treatment of breast cancer].
    Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
    Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dosage treatment of breast cancer--in favour].
    Zander AR; Kröger N
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1091. PubMed ID: 11602918
    [No Abstract]   [Full Text] [Related]  

  • 15. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    Venturini M; Del Mastro L; Aitini E; Baldini E; Caroti C; Contu A; Testore F; Brema F; Pronzato P; Cavazzini G; Sertoli MR; Canavese G; Rosso R; Bruzzi P
    J Natl Cancer Inst; 2005 Dec; 97(23):1724-33. PubMed ID: 16333028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.
    Chirivella I; Bermejo B; Insa A; Pérez-Fidalgo A; Magro A; Rosello S; García-Garre E; Martín P; Bosch A; Lluch A
    Breast Cancer Res Treat; 2009 Apr; 114(3):479-84. PubMed ID: 18463977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of carcinoma of the breast.
    Huguley CM
    J Med Assoc Ga; 1972 Dec; 61(12):402-3. PubMed ID: 4644928
    [No Abstract]   [Full Text] [Related]  

  • 20. Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.
    Alliot C
    J Clin Oncol; 2005 Jun; 23(18):4237-8; author reply 4238-9. PubMed ID: 15961776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.